Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: University of California, Irvine
Condition: Carcinoma, Transitional Cell
NCT04039867
Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
Trial was terminated due to halt in funding.